Form D · Other Technology
GENTEL BIOSCIENCES INC
Madison, WI · CIK 0001392432
Offering snapshot reported Dec 10, 2008 · SEC filing
- Reported sold
- $2.74M Offering amount: $3M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 10, 2008 | Initial | $2,742,739 | No comparison | Not reported | SEC filing |
| Mar 5, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-100950
Source: Form D, filed Dec 10, 2008. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert De Bruin | Director |
| Randy Durnell | Executive |
| Kenneth U. Johnson | Director |
| Chris Kendrick Parker | Director |
| Larry J. Liozzo | Director |
| Tore H. Rasmussen | Director |
| Lloyd M. Smith | Director |
| Alex D. Vodenlich | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
5500 Nobel Drive Suite 230
Madison, WI, 53711
Madison, WI, 53711